SCHEMBL3633025

SCHEMBL3633025

COc1ccc2cc(C(C(=O)O)N3CCN(C)CC3)ccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 6/20 0.56
AKR1C2 P52895 6/20 0.56
PTGS2 P35354 3/20 0.56
PTGS1 P23219 3/20 0.56
TSHR P16473 3/20 0.56
CDC42 P60953 1/20 0.56
RAC1 P63000 1/20 0.56
CYP1A2 P05177 1/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
AKR1C1 Q04828 1/20 0.52
POLB P06746 1/20 0.47
ALOX5 P09917 1/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HRH4 Q9H3N8 2/20 0.45
NPC1 O15118 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14428555 0.85 L3MBTL1 (0.53) POLBKDM4ELMNAMAPTTDP1
SCHEMBL13044326 0.85 HPGD (0.50) TSHRLMNA
Hydrochloric Acid SCHEMBL3637935 0.84 LMNA (0.51) TSHRLMNATDP1
SCHEMBL13476433 0.82 AKR1C3 (0.48) AKR1C3AKR1C2PTGS2PTGS1TSHR
SCHEMBL8235635 0.81 ACHE (0.49) TSHRL3MBTL1
SCHEMBL3728026 0.80 LMNA (0.40) AKR1C3AKR1C2TSHRKDM4ELMNA
SCHEMBL3639648 0.78 CLK1 (0.46) AKR1C3AKR1C2PTGS2PTGS1TSHR
SCHEMBL15934093 0.76 POLB (0.73) AKR1C3AKR1C2PTGS2PTGS1TSHR
SCHEMBL13044353 0.76 LMNA (0.39) TSHRLMNAHRH4
Hydrochloric Acid SCHEMBL3637036 0.75 LMNA (0.41) TSHRLMNATDP1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
EP-2167466-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR Glaxo Group Limited (GB) 2010-03-31 EP disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R AKR1C3 2955/4885AKR1C2 2311/4885PTGS2 2215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.